Expert and Patient Perspectives on AE Management With FGFR Inhibitors in Cholangiocarcinoma

Season 10 Episode 10  ·  Jan 29, 2024, 09:35 PM

Headliner
Share
Subscribe

Goyal, Bishop, Kelley, and Kuhlman discuss ways to prepare patients with cholangiocarcinoma for FGFR inhibitor–related adverse effects.

Share
Subscribe
Next
Lunning and Brander Emphasize the Importance of Early CLL Diagnosis and Treatment
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air